Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Adagene Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 5.72M | 3.09M | −2.63M (−46.0%) |
| Value | $11.3M | $6.03M | −$5.22M (−46.4%) |
New holders (4)
Institutions that held Adagene Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exome Asset Management LLC | 1,060,221 | $2.00M | 0.99% |
| SmartHarvest Portfolios, LLC | 38,771 | $73.3K | 0.03% |
| Nomura Holdings Inc | 18,000 | $34.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 12 | $23 | 0.00% |
Sold out (4)
Institutions that held Adagene Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| General Atlantic LLC | 3,782,339 | $7.53M |
| Gordian Capital Singapore Pte Ltd | 48,342 | $96.2K |
| Marex Group plc | 23,419 | $46.6K |
| XTX Topco Ltd | 10,909 | $21.5K |